Exact Mass: 290.06982960000005

Exact Mass Matches: 290.06982960000005

Found 7 metabolites which its exact mass value is equals to given mass value 290.06982960000005, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

1H-Pyrrole-2,5-dione, 1-[4-(2-benzoxazolyl)phenyl]-

1-[4-(1,3-benzoxazol-2-yl)phenyl]-2,5-dihydro-1H-pyrrole-2,5-dione

C17H10N2O3 (290.069139)


   

Di-Ph ester-(2RS,3SR)-(3-Methyloxiranyl)phosphonic acid

Di-Ph ester-(2RS,3SR)-(3-Methyloxiranyl)phosphonic acid

C15H15O4P (290.07079200000004)


   
   

12-Oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxylic acid

12-Oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxylic acid

C17H10N2O3 (290.069139)


   

1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one dihydrochloride

1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one dihydrochloride

C11H16Cl2N4O (290.07011059999996)


   

2-{6[(2Amino-2-carboxyethyl)-sulfanyl]1-hydroxycyclohex-2-en1yl}-acetate

2-{6[(2Amino-2-carboxyethyl)-sulfanyl]1-hydroxycyclohex-2-en1yl}-acetate

C11H16NO6S- (290.06982960000005)


   

AKB-6899

AKB-6899

C14H11FN2O4 (290.07028180000003)


AKB-6899, a prolyl hydroxylase domain 3 (PHD3) inhibitor, is a selective HIF-2α stabilizer. AKB-6899 also increases soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages, and has antitumor and antiangiogenic effects[1].